Adjuvant compound
AssigneeISA Pharmaceuticals B.V.
InventorsFerdinand Antonius Ossendorp, Cornelis Johannes Maria Melief, Selina Khan, Dmitri Viktorovitsj Filippov, Gijsbert Arie Van Der Marel
Life of this patent
Estimating the term…
Loading patent…
AssigneeISA Pharmaceuticals B.V.
InventorsFerdinand Antonius Ossendorp, Cornelis Johannes Maria Melief, Selina Khan, Dmitri Viktorovitsj Filippov, Gijsbert Arie Van Der Marel
Estimating the term…
The invention is directed to a compound according to the formula [1] wherein R1 and R2 are branched or straight groups having up to 17 atoms selected from carbon, nitrogen, oxygen and sulphur, n is 0 to and including 18, Y is sulphur or selene, X is S or 0 and R is —OH or an organic group comprising one or more peptides, one or more nucleic acids, one or more antibodies or combinations thereof. The invention is also directed to process for preparing said compound and the use of said compound as an adjuvant. The invention is also directed to a composition comprising said compound and the use of said composition, for example as a vaccine composition.
A compound represented by the following formula [1]:
Dependencies are inferred from the claim text.